Digestives & Intestinal Remedies - Cyprus

  • Cyprus
  • In 2024, the Digestives & Intestinal Remedies market market in Cyprus generated a revenue of US$9.38m.
  • It is projected to experience an annual growth rate of 4.72% (CAGR 2024-2029).
  • When compared to other countries worldwide, in China leads the market with a revenue of US$4,408.00m in 2024.
  • Taking into account the population figures, the per person revenue in Cyprus amounted to US$7.39 in 2024.
  • Cyprus has seen an increase in demand for digestive and intestinal remedies, driven by the country's aging population and changing dietary habits.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Cyprus has been experiencing steady growth in recent years.

Customer preferences:
Customers in Cyprus have shown a growing preference for natural and herbal remedies for digestive issues. This shift towards natural products can be attributed to increasing health consciousness and a desire for more sustainable and environmentally friendly options. Additionally, customers are increasingly seeking products that are free from artificial ingredients and chemicals, as well as those that are gentle on the digestive system.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Cyprus is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are good for the digestive system. They are believed to promote a healthy gut flora and improve digestion. The demand for probiotics has been driven by growing awareness of their health benefits and their effectiveness in treating digestive issues.Another trend in the market is the rise of functional foods and beverages that promote digestive health. These products are fortified with ingredients such as fiber, prebiotics, and enzymes that aid digestion. They are often marketed as a convenient and tasty way to support digestive health and prevent common digestive problems.

Local special circumstances:
Cyprus has a high prevalence of digestive disorders, such as irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). This has created a strong demand for Digestives & Intestinal Remedies in the market. Consumers are actively seeking products that can alleviate their symptoms and improve their overall digestive health.

Underlying macroeconomic factors:
The growing Digestives & Intestinal Remedies market in Cyprus can also be attributed to several underlying macroeconomic factors. The country has experienced stable economic growth in recent years, which has led to increased disposable income and consumer spending. As a result, consumers are more willing to invest in their health and are seeking products that can improve their overall well-being.In addition, the aging population in Cyprus has contributed to the growth of the Digestives & Intestinal Remedies market. Older adults are more prone to digestive issues and are actively seeking products that can help manage their symptoms and improve their quality of life.Overall, the Digestives & Intestinal Remedies market in Cyprus is developing in response to changing customer preferences, local special circumstances, and underlying macroeconomic factors. The increasing demand for natural and herbal remedies, the popularity of probiotics, and the rise of functional foods and beverages are driving the growth of the market. Additionally, the high prevalence of digestive disorders and the country's stable economic growth are contributing to the expansion of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)